Skip to main content
Top
Published in: Neurological Research and Practice 1/2022

01-12-2022 | Vaccination | Letter to the editor

LGI-1 encephalopathy following ChAdOx1 nCov-19 vaccination

Authors: Tamara Garibashvili, Josef Georg Heckmann

Published in: Neurological Research and Practice | Issue 1/2022

Login to get access

Abstract

A 71-year-old male patient was diagnosed with LGI1 encephalopathy 4 weeks following a first ChAdOx1 nCov-19 vaccination. Extensive work-up including analysis of CSF and PET examination did not reveal a tangible cause so that a vaccine-associated encephalopathy was considered as differential diagnosis. Under steroid treatment, the faciobrachial dystonic seizures subsided.
Literature
1.
go back to reference Walter, A., & Kraemer, M. (2021). A neurologist’s rhombencephalitis after comirnaty vaccination: A change of perspective. Neurological Research and Practice., 3(1), 56.CrossRef Walter, A., & Kraemer, M. (2021). A neurologist’s rhombencephalitis after comirnaty vaccination: A change of perspective. Neurological Research and Practice., 3(1), 56.CrossRef
2.
go back to reference Finsterer, J., Scorza, F. A., Scorza, C. A., & Fiorini, A. C. (2022). Diagnosing SARS-CoV-2 vaccination associated rhombencephalitis requires comprehensive work-up and exclusion of differentials. Neurological Research and Practice, 4(1), 10.CrossRef Finsterer, J., Scorza, F. A., Scorza, C. A., & Fiorini, A. C. (2022). Diagnosing SARS-CoV-2 vaccination associated rhombencephalitis requires comprehensive work-up and exclusion of differentials. Neurological Research and Practice, 4(1), 10.CrossRef
3.
go back to reference Smyth, D., Kyaw, K. M., Legister, A., MacFarlane, G., Sankar, U. U., Patel, M., Clough, C., Kulendran, A. & Mulroy, E. (2022) Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies. Journal of the Neurological Sciences. in press. Smyth, D., Kyaw, K. M., Legister, A., MacFarlane, G., Sankar, U. U., Patel, M., Clough, C., Kulendran, A. & Mulroy, E. (2022) Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies. Journal of the Neurological Sciences. in press.
4.
go back to reference Zlotnik, Y., Gadoth, A., Abu-Salameh, I., Horev, A., Novoa, R., & Ifergane, G. (2022). Case Report: Anti-LGI1 encephalitis following COVID-19 vaccination. Frontiers in Immunology, 12, 813487.CrossRef Zlotnik, Y., Gadoth, A., Abu-Salameh, I., Horev, A., Novoa, R., & Ifergane, G. (2022). Case Report: Anti-LGI1 encephalitis following COVID-19 vaccination. Frontiers in Immunology, 12, 813487.CrossRef
5.
go back to reference Bien, C. G., & Bien, C. I. (2020). Autoimmune encephalitis in children and adolescents. Neurological Research and Practice, 2, 4.CrossRef Bien, C. G., & Bien, C. I. (2020). Autoimmune encephalitis in children and adolescents. Neurological Research and Practice, 2, 4.CrossRef
6.
go back to reference Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., & Glaser, C. A. (2016). A clinical approach to diagnosis of autoimmune encephalitis. The Lancet Neurology, 15(4), 391–404.CrossRef Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., & Glaser, C. A. (2016). A clinical approach to diagnosis of autoimmune encephalitis. The Lancet Neurology, 15(4), 391–404.CrossRef
7.
go back to reference Uy, C. E., Binks, S., & Irani, S. R. (2021). Autoimmune encephalitis: Clinical spectrum and management. Practical Neurology, 21, 412–423.CrossRef Uy, C. E., Binks, S., & Irani, S. R. (2021). Autoimmune encephalitis: Clinical spectrum and management. Practical Neurology, 21, 412–423.CrossRef
8.
go back to reference Dalmau, J., & Graus, F. (2018). Antibody-mediated encephalitis. The New England Journal of Medicine, 378, 840–851.CrossRef Dalmau, J., & Graus, F. (2018). Antibody-mediated encephalitis. The New England Journal of Medicine, 378, 840–851.CrossRef
9.
go back to reference Zuhorn, F., Graf, T., Klingebiel, R., Schäbitz, W. R., Rogalewski, A. Seltene Enzephalitis nach Impfung gegen SARS-CoV-2. Nervenarzt 2022, in press. Zuhorn, F., Graf, T., Klingebiel, R., Schäbitz, W. R., Rogalewski, A. Seltene Enzephalitis nach Impfung gegen SARS-CoV-2. Nervenarzt 2022, in press.
10.
go back to reference Finsterer, J. (2022). Neurological side effects of SARS-CoV-2 vaccinations. Acta Neurologica Scandinavica, 145, 5–9.CrossRef Finsterer, J. (2022). Neurological side effects of SARS-CoV-2 vaccinations. Acta Neurologica Scandinavica, 145, 5–9.CrossRef
11.
go back to reference Greinacher, A., Thiele, T., Warkentin, T. E., Weisser, K., Kyrle, P. A., & Eichinger, S. (2021). Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. New England Journal of Medicine, 384, 2092–2101.CrossRef Greinacher, A., Thiele, T., Warkentin, T. E., Weisser, K., Kyrle, P. A., & Eichinger, S. (2021). Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. New England Journal of Medicine, 384, 2092–2101.CrossRef
12.
go back to reference Lunn, M. P., Cornblath, D. R., Jacobs, B. C., Querol, L., van Doorn, P. A., Hughes, R. A., & Willison, H. J. (2021). COVID-19 vaccine and Guillain-Barré syndrome: Let’s not leap to associations. Brain, 144, 357–360.CrossRef Lunn, M. P., Cornblath, D. R., Jacobs, B. C., Querol, L., van Doorn, P. A., Hughes, R. A., & Willison, H. J. (2021). COVID-19 vaccine and Guillain-Barré syndrome: Let’s not leap to associations. Brain, 144, 357–360.CrossRef
Metadata
Title
LGI-1 encephalopathy following ChAdOx1 nCov-19 vaccination
Authors
Tamara Garibashvili
Josef Georg Heckmann
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Neurological Research and Practice / Issue 1/2022
Electronic ISSN: 2524-3489
DOI
https://doi.org/10.1186/s42466-022-00187-8

Other articles of this Issue 1/2022

Neurological Research and Practice 1/2022 Go to the issue